Philip J. Barter

School of Medical Sciences, UNSW Australia

Affiliated withUNSW Australia University of Sydney

Research Area

Biography

Philip J. Barter has not added Biography.
If you are Philip J. Barter and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 15	2017

Other Publications

Article	Year
Effect of high-density lipoproteins on the expression of adhesion molecules in endothelial cells. Current opinion in lipidology\| PubMed ID: 12045398	2002
Coronary plaque regression: role of low density lipoprotein-apheresis. Journal of the American College of Cardiology\| PubMed ID: 12106924	2002
Evidence that phospholipids play a key role in pre-beta apoA-I formation and high-density lipoprotein remodeling. Biochemistry\| PubMed ID: 12369845	2002
Metabolism of apoA-I as lipid-free protein or as component of discoidal and spherical reconstituted HDLs: studies in wild-type and hepatic lipase transgenic rabbits. Arteriosclerosis, thrombosis, and vascular biology\| PubMed ID: 12426224	2002
Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis. Arteriosclerosis, thrombosis, and vascular biology\| PubMed ID: 12588754	2003
Apolipoprotein A-II inhibits high density lipoprotein remodeling and lipid-poor apolipoprotein A-I formation. The Journal of biological chemistry\| PubMed ID: 12690114	2003
Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-I. Arteriosclerosis, thrombosis, and vascular biology\| PubMed ID: 14592845	2004
Evidence that hepatic lipase and endothelial lipase have different substrate specificities for high-density lipoprotein phospholipids. Biochemistry\| PubMed ID: 14622025	2003
Effects of switching statins on achievement of lipid goals: Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURY I) study. American heart journal\| PubMed ID: 15077101	2004
High-density lipoproteins neutralize C-reactive protein proinflammatory activity. Circulation\| PubMed ID: 15078800	2004
Apolipoprotein E enhances hepatic lipase-mediated hydrolysis of reconstituted high-density lipoprotein phospholipid and triacylglycerol in an isoform-dependent manner. Biochemistry\| PubMed ID: 15379569	2004
Antiinflammatory properties of HDL. Circulation research\| PubMed ID: 15486323	2004
Relation between atherogenic dyslipidemia and the Adult Treatment Program-III definition of metabolic syndrome (Genetic Epidemiology of Metabolic Syndrome Project). The American journal of cardiology\| PubMed ID: 15642551	2005
Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits. Circulation\| PubMed ID: 15781735	2005
High-density lipoproteins as therapeutic targets. Current opinion in lipidology\| PubMed ID: 15891397	2005
Multiple QTLs influencing triglyceride and HDL and total cholesterol levels identified in families with atherogenic dyslipidemia. Journal of lipid research\| PubMed ID: 16061952	2005
Impact of short-term administration of high-density lipoproteins and atorvastatin on atherosclerosis in rabbits. Arteriosclerosis, thrombosis, and vascular biology\| PubMed ID: 16141405	2005
Formation of high density lipoproteins containing both apolipoprotein A-I and A-II in the rabbit. Journal of lipid research\| PubMed ID: 16222033	2006
Regulation of reconstituted high density lipoprotein structure and remodeling by apolipoprotein E. Journal of lipid research\| PubMed ID: 16452453	2006
Targeting cholesteryl ester transfer protein for the prevention and management of cardiovascular disease. Journal of the American College of Cardiology\| PubMed ID: 16458126	2006
High-density lipoproteins enhance progenitor-mediated endothelium repair in mice. Arteriosclerosis, thrombosis, and vascular biology\| PubMed ID: 16528007	2006
Cardioprotective properties of fibrates: which fibrate, which patients, what mechanism? Circulation\| PubMed ID: 16567579	2006
Relationship between the concentration and antiatherogenic activity of high-density lipoproteins. Current opinion in lipidology\| PubMed ID: 16832163	2006
Consumption of saturated fat impairs the anti-inflammatory properties of high-density lipoproteins and endothelial function. Journal of the American College of Cardiology\| PubMed ID: 16904539	2006
Homocysteine and cardiovascular disease: is HDL the link? Circulation research\| PubMed ID: 16973911	2006
Is it appropriate to make statins available over the counter? The argument against the appropriateness of over-the-counter statins. Circulation\| PubMed ID: 16982953	2006
Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia. The New England journal of medicine\| PubMed ID: 17387131	2007
N-Glycosylation regulates endothelial lipase-mediated phospholipid hydrolysis in apoE- and apoA-I-containing high density lipoproteins. Journal of lipid research\| PubMed ID: 17545692	2007
Low dose apolipoprotein A-I rescues carotid arteries from inflammation in vivo. Atherosclerosis\| PubMed ID: 17586510	2008
Is there a role for fibrates in the management of dyslipidemia in the metabolic syndrome? Arteriosclerosis, thrombosis, and vascular biology\| PubMed ID: 17717290	2008
Identification and characterization of two non-secreted PCSK9 mutants associated with familial hypercholesterolemia in cohorts from New Zealand and South Africa. Atherosclerosis\| PubMed ID: 17765244	2008
Remodeling of apolipoprotein E-containing spherical reconstituted high density lipoproteins by phospholipid transfer protein. Journal of lipid research\| PubMed ID: 17921435	2008
Effects of torcetrapib in patients at high risk for coronary events. The New England journal of medicine\| PubMed ID: 17984165	2007
New insights into the role of HDL as an anti-inflammatory agent in the prevention of cardiovascular disease. Current cardiology reports\| PubMed ID: 17999875	2007
Plasma PCSK9 concentrations correlate with LDL and total cholesterol in diabetic patients and are decreased by fenofibrate treatment. Clinical chemistry\| PubMed ID: 18436719	2008
Antiinflammatory actions of HDL: a new insight. Arteriosclerosis, thrombosis, and vascular biology\| PubMed ID: 18946054	2008
The metabolism and anti-atherogenic properties of HDL. Journal of lipid research\| PubMed ID: 19033213	2009
Acute hypertriglyceridaemia in humans increases the triglyceride content and decreases the anti-inflammatory capacity of high density lipoproteins. Atherosclerosis\| PubMed ID: 19111829	2009
Genome-wide linkage and association analyses to identify genes influencing adiponectin levels: the GEMS Study. Obesity (Silver Spring, Md.)\| PubMed ID: 19165155	2009
Relationships of HDL cholesterol, ApoA-I, and ApoA-II with homocysteine and creatinine in patients with type 2 diabetes treated with fenofibrate. Arteriosclerosis, thrombosis, and vascular biology\| PubMed ID: 19325138	2009
Cholesterol metabolism and pancreatic beta-cell function. Current opinion in lipidology\| PubMed ID: 19417651	2009
Reconstituted high-density lipoprotein suppresses leukocyte NADPH oxidase activation by disrupting lipid rafts. Free radical research\| PubMed ID: 19521892	2009
Genetic association and interaction analysis of USF1 and APOA5 on lipid levels and atherosclerosis. Arteriosclerosis, thrombosis, and vascular biology\| PubMed ID: 19910639	2010
Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: analysis of the VOYAGER Database. Journal of lipid research\| PubMed ID: 19965573	2010
The 5A apolipoprotein A-I mimetic peptide displays antiinflammatory and antioxidant properties in vivo and in vitro. Arteriosclerosis, thrombosis, and vascular biology\| PubMed ID: 19965776	2010
Meta-analysis of comparative efficacy of increasing dose of Atorvastatin versus Rosuvastatin versus Simvastatin on lowering levels of atherogenic lipids (from VOYAGER). The American journal of cardiology\| PubMed ID: 20102893	2010
Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-I. Arteriosclerosis, thrombosis, and vascular biology\| PubMed ID: 20110571	2010
Evidence that niacin inhibits acute vascular inflammation and improves endothelial dysfunction independent of changes in plasma lipids. Arteriosclerosis, thrombosis, and vascular biology\| PubMed ID: 20167660	2010
Effects of high-density lipoproteins on pancreatic beta-cell insulin secretion. Arteriosclerosis, thrombosis, and vascular biology\| PubMed ID: 20466975	2010
Anti-inflammatory effects of apolipoprotein A-I in the rabbit. Atherosclerosis\| PubMed ID: 20609437	2010
High-density lipoproteins suppress chemokines and chemokine receptors in vitro and in vivo. Arteriosclerosis, thrombosis, and vascular biology\| PubMed ID: 20702809	2010
The relationship between cholesteryl ester transfer protein and cardiovascular risk. Clinical chemistry\| PubMed ID: 20739636	2010
Lipid-free apolipoprotein A-I and discoidal reconstituted high-density lipoproteins differentially inhibit glucose-induced oxidative stress in human macrophages. Arteriosclerosis, thrombosis, and vascular biology\| PubMed ID: 21330603	2011
Inhibition of rupture of established atherosclerotic plaques by treatment with apolipoprotein A-I. Cardiovascular research\| PubMed ID: 21354994	2011
The apolipoprotein A-I mimetic peptide ETC-642 exhibits anti-inflammatory properties that are comparable to high density lipoproteins. Atherosclerosis\| PubMed ID: 21571275	2011
The causes and consequences of low levels of high density lipoproteins in patients with diabetes. Diabetes & metabolism journal\| PubMed ID: 21738891	2011
Effect of torcetrapib on glucose, insulin, and hemoglobin A1c in subjects in the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) trial... Circulation\| PubMed ID: 21804130	2011
Association of lower total bilirubin level with statin usage: the United States National Health and Nutrition Examination Survey 1999-2008. Atherosclerosis\| PubMed ID: 21840000	2011
Predictive value of different HDL particles for the protection against or risk of coronary heart disease. Biochimica et biophysica acta\| PubMed ID: 22051746	2012
Effect of two intensive statin regimens on progression of coronary disease. The New England journal of medicine\| PubMed ID: 22085316	2011
Niacin inhibits vascular inflammation via the induction of heme oxygenase-1. Circulation\| PubMed ID: 22095827	2012
The apolipoprotein A-I mimetic peptide, ETC-642, reduces chronic vascular inflammation in the rabbit. Lipids in health and disease\| PubMed ID: 22128776	2011
ApoA-I induction as a potential cardioprotective strategy: rationale for the SUSTAIN and ASSURE studies. Cardiovascular drugs and therapy\| PubMed ID: 22349989	2012
The inhibition of cholesteryl ester transfer protein: a long and winding road. Journal of lipid research\| PubMed ID: 22496386	2012
Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk. Journal of lipid research\| PubMed ID: 22550134	2012
Plasma PCSK9 levels and clinical outcomes in the TNT (Treating to New Targets) trial: a nested case-control study. Journal of the American College of Cardiology\| PubMed ID: 22575316	2012
Relationship between atorvastatin dose and the harm caused by torcetrapib. Journal of lipid research\| PubMed ID: 22941786	2012
High-density lipoproteins inhibit vascular endothelial inflammation by increasing 3β-hydroxysteroid-Δ24 reductase expression and inducing heme oxygenase-1. Circulation research\| PubMed ID: 23123430	2013
Effects of dalcetrapib in patients with a recent acute coronary syndrome. The New England journal of medicine\| PubMed ID: 23126252	2012
Long-term fenofibrate therapy increases fibroblast growth factor 21 and retinol-binding protein 4 in subjects with type 2 diabetes. The Journal of clinical endocrinology and metabolism\| PubMed ID: 23144467	2012
Arthritis: its prevalence, risk factors, and association with cardiovascular diseases in the United States, 1999 to 2008. Annals of epidemiology\| PubMed ID: 23218811	2013
Dalcetrapib in patients with an acute coronary syndrome. The New England journal of medicine\| PubMed ID: 23445098	2013
The conundrum of C-reactive protein as a risk marker for cardiovascular risk assessment: insight from EPIC-Norfolk and JUPITER. European heart journal\| PubMed ID: 23482520	2013
Achievement of 2011 European low-density lipoprotein cholesterol (LDL-C) goals of either <70 mg/dl or ≥ 50% reduction in high-risk patients: results from VOYAGER. Atherosclerosis\| PubMed ID: 23510828	2013
Achievement of LDL-C goals depends on baseline LDL-C and choice and dose of statin: an analysis from the VOYAGER database. European journal of preventive cardiology\| PubMed ID: 23644489	2013
Trends in C-reactive protein levels in US adults from 1999 to 2010. American journal of epidemiology\| PubMed ID: 23669654	2013
Cardioprotective functions of HDLs. Journal of lipid research\| PubMed ID: 23812558	2014
High-density lipoproteins: a consensus statement from the National Lipid Association. Journal of clinical lipidology\| PubMed ID: 24079290	2013
High density lipoproteins improve insulin sensitivity in high-fat diet-fed mice by suppressing hepatic inflammation. Journal of lipid research\| PubMed ID: 24347528	2014
Inhibition of arthritis in the Lewis rat by apolipoprotein A-I and reconstituted high-density lipoproteins. Arteriosclerosis, thrombosis, and vascular biology\| PubMed ID: 24357062	2014
Regulation of high-density lipoprotein metabolism. Circulation research\| PubMed ID: 24385508	2014
High density lipoprotein: a therapeutic target in type 2 diabetes. Endocrinology and metabolism (Seoul, Korea)\| PubMed ID: 24396675	2013
HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells. Nature communications\| PubMed ID: 24576947	2014
Elevated plasma PCSK9 level is equally detrimental for patients with nonfamilial hypercholesterolemia and heterozygous familial hypercholesterolemia, irrespective of low-density lipoprotein ... Journal of the American College of Cardiology\| PubMed ID: 24632287	2014
Cardiovascular drugs that increase the risk of new-onset diabetes. American heart journal\| PubMed ID: 24655688	2014
Effect of change in body weight on incident diabetes mellitus in patients with stable coronary artery disease treated with atorvastatin (from the treating to new targets study). The American journal of cardiology\| PubMed ID: 24666618	2014
The relationship between total bilirubin levels and total mortality in older adults: the United States National Health and Nutrition Examination Survey (NHANES) 1999-2004. PloS one\| PubMed ID: 24728477	2014
The relationship between insulin resistance and vascular calcification in coronary arteries, and the thoracic and abdominal aorta: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis\| PubMed ID: 25108074	2014
Apolipoprotein A-I increases insulin secretion and production from pancreatic β-cells via a G-protein-cAMP-PKA-FoxO1-dependent mechanism. Arteriosclerosis, thrombosis, and vascular biology\| PubMed ID: 25147338	2014
Antiatherosclerotic effects of long-term maximally intensive statin therapy after acute coronary syndrome: insights from Study of Coronary Atheroma by Intravascular Ultrasound: Effect of Ros... Arteriosclerosis, thrombosis, and vascular biology\| PubMed ID: 25212234	2014
The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study. Diabetologia\| PubMed ID: 25425220	2015
Cholesteryl ester transfer protein inhibition enhances endothelial repair and improves endothelial function in the rabbit. Arteriosclerosis, thrombosis, and vascular biology\| PubMed ID: 25633313	2015
Relationship of pericardial fat with biomarkers of inflammation and hemostasis, and cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis\| PubMed ID: 25682037	2015
Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial. Lancet (London, England)\| PubMed ID: 26047975	2015
Relationship of fibroblast growth factor 21 with baseline and new on-study microvascular disease in the Fenofibrate Intervention and Event Lowering in Diabetes study. Diabetologia\| PubMed ID: 26055067	2015
To what extent do high-intensity statins reduce low-density lipoprotein cholesterol in each of the four statin benefit groups identified by the 2013 American College of Cardiology/American H... Atherosclerosis\| PubMed ID: 26074319	2015
Relationship of pericardial fat with lipoprotein distribution: The Multi-Ethnic study of atherosclerosis. Atherosclerosis\| PubMed ID: 26117404	2015
Increasing HDL levels by inhibiting cholesteryl ester transfer protein activity in rabbits with hindlimb ischemia is associated with increased angiogenesis. International journal of cardiology\| PubMed ID: 26204569	2015
Is Cholesteryl Ester Transfer Protein Inhibition an Effective Strategy to Reduce Cardiovascular Risk? CETP Inhibition as a Strategy to Reduce Cardiovascular Risk: The Pro Case. Circulation\| PubMed ID: 26240263	2015
Doses of rosuvastatin, atorvastatin and simvastatin that induce equal reductions in LDL-C and non-HDL-C: Results from the VOYAGER meta-analysis. European journal of preventive cardiology\| PubMed ID: 26246463	2016
Apolipoprotein A-I Limits the Negative Effect of Tumor Necrosis Factor on Lymphangiogenesis. Arteriosclerosis, thrombosis, and vascular biology\| PubMed ID: 26359513	2015
Reduction in PCSK9 levels induced by anacetrapib: an off-target effect? Journal of lipid research\| PubMed ID: 26378095	2015
Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE Trial. American journal of cardiovascular drugs : drugs, devices, and other interventions\| PubMed ID: 26385396	2016
Speed kills in more ways than one: Methamphetamine and atherosclerosis. Atherosclerosis\| PubMed ID: 26522439	2015
Targeting High-density Lipoproteins to Reduce Cardiovascular Risk: What Is the Evidence? Clinical therapeutics\| PubMed ID: 26548324	2015
Apolipoprotein A-I interactions with insulin secretion and production. Current opinion in lipidology\| PubMed ID: 26655291	2016
Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: Rationale and design of the ACCELERATE tr... American heart journal\| PubMed ID: 26678626	2015
Cholesteryl Ester Transfer Protein Inhibition Is Not Yet Dead--Pro. Arteriosclerosis, thrombosis, and vascular biology\| PubMed ID: 26848159	2016
A novel class of copper(II)- and zinc(II)-bound non-steroidal anti-inflammatory drugs that inhibits acute inflammation in vivo. Cell & bioscience\| PubMed ID: 26855766	2016
High-Density Lipoprotein-Associated miR-223 Is Altered after Diet-Induced Weight Loss in Overweight and Obese Males. PloS one\| PubMed ID: 26962854	2016
Inhibition of inflammatory signaling pathways in 3T3-L1 adipocytes by apolipoprotein A-I. FASEB journal : official publication of the Federation of American Societies for Experimental Biology\| PubMed ID: 26965683	2016
A VOYAGER Meta-Analysis of the Impact of Statin Therapy on Low-Density Lipoprotein Cholesterol and Triglyceride Levels in Patients With Hypertriglyceridemia. The American journal of cardiology\| PubMed ID: 26969416	2016
New Era of Lipid-Lowering Drugs. Pharmacological reviews\| PubMed ID: 26983688	2016
Coronary artery disease: Scavenger receptor class B1--a target to reduce CHD risk? Nature reviews. Cardiology\| PubMed ID: 27053456	2016
In vivo PET imaging with [(18)F]FDG to explain improved glucose uptake in an apolipoprotein A-I treated mouse model of diabetes. Diabetologia\| PubMed ID: 27193916	2016
Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholest... The lancet. Diabetes & endocrinology\| PubMed ID: 27246162	2016
Variability of low-density lipoprotein cholesterol response with different doses of atorvastatin, rosuvastatin, and simvastatin: results from VOYAGER. European heart journal. Cardiovascular pharmacotherapy\| PubMed ID: 27533947	2016
Impact of Perturbed Pancreatic β-Cell Cholesterol Homeostasis on Adipose Tissue and Skeletal Muscle Metabolism. Diabetes\| PubMed ID: 27702832	2016
Treatment With Dalcetrapib Modifies the Relationship Between High-Density Lipoprotein Cholesterol and C-Reactive Protein. Journal of the American College of Cardiology\| PubMed ID: 27908356	2016
Erratum. Impact of Perturbed Pancreatic β-Cell Cholesterol Homeostasis on Adipose Tissue and Skeletal Muscle Metabolism. Diabetes 2016;65:3610-3620. Diabetes\| PubMed ID: 27908917	2017
Aldosterone Does Not Predict Cardiovascular Events Following Acute Coronary Syndrome in Patients Initially Without Heart Failure. Journal of the American Heart Association\| PubMed ID: 28073769	2017
The ATP binding cassette transporter, ABCG1, localizes to cortical actin filaments. Scientific reports\| PubMed ID: 28165022	2017